You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Caffeine Intake is Associated with a Lower Risk of Cognitive Decline: A Cohort Study from Portugal

Issue title: Therapeutic Opportunities for Caffeine in Alzheimer's Disease and Other Neurodegenerative Disorders

Guest editors: Rodrigo A. Cunhax and Alexandre de Mendonçay

Article type: Research Article

Authors: Santos, Catarinaa; * | Lunet, Nunoa | Azevedo, Anaa | de Mendonça, Alexandreb | Ritchie, Karenc | Barros, Henriquea

Affiliations: [a] Department of Hygiene and Epidemiology, Porto University Medical School and Institute of Public Health of the University of Porto (ISPUP), Porto, Portugal | [b] Department of Neurology and Laboratory of Neurosciences, University of Lisbon, Lisbon, Portugal | [c] Nervous System Pathologies: Epidemiological and Clinical Research, La Colombière Hospital, Montpellier, France | [x] Center for Neuroscience and Cell Biology of Coimbra and Faculty of Medicine, University of Coimbra, Portugal | [y] Institute of Molecular Medicine and Faculty of Medicine, University of Lisbon, Portugal

Correspondence: [*] Correspondence to: Catarina Santos, Serviço de Higiene e Epidemiologia, Faculdade de Medicina da Universidade do Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal. Tel.: +351 225513652; Fax: +351 225 513 653; E-mail: [email protected].

Keywords: Caffeine, cohort studies, dementia, gender

DOI: 10.3233/JAD-2010-091303

Journal: Journal of Alzheimer's Disease, vol. 20, no. s1, pp. S175-S185, 2010

Published: 14 April 2010
Get PDF open access

Abstract

Alzheimer's disease has emerged in recent decades as a major health problem and the role of lifestyles in the modulation of risk has been increasingly recognized. Recent epidemiological studies suggest a protective effect for caffeine intake in dementia. We aimed to quantify the association between caffeine dietary intake and cognitive decline, in a cohort of adults living in Porto. A cohort of 648 subjects aged ⩾65 years was recruited between 1999–2003. Follow-up evaluation (2005–2008) was carried out on 58.2% of the eligible participants and 10.9% were deceased. Caffeine exposure in the year preceding baseline evaluation was assessed with a validated food frequency questionnaire. Cognitive evaluation consisted of baseline and follow-up Mini-Mental State Examination (MMSE). Cognitive decline was defined by a decrease ⩾ 2 points in the MMSE score between evaluations. Relative risk (RR) and 95% confidence interval (95%CI) estimates adjusted for age, education, smoking, alcohol drinking, body mass index, hypertension, and diabetes were computed using Poisson regression. Caffeine intake (> 62 mg/day [3rd third] vs. < 22 mg/day [1st third]) was associated with a lower risk of cognitive decline in women (RR=0.49, 95%CI 0.24–0.97), but not significantly in men (RR=0.65, 95%CI 0.27–1.54). Our study confirms the negative association between caffeine and cognitive decline in women.

Show more